원격 환자 모니터링 기기 시장 : 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of remote patient monitoring (RPM) devices Market

The global remote patient monitoring (RPM) devices market is experiencing remarkable growth due to the increasing prevalence of chronic diseases, rapid digital transformation in healthcare, and growing adoption of telehealth solutions. According to the report, the global remote patient monitoring devices market size was valued at USD 59.92 billion in 2025. The market is projected to grow from USD 71.29 billion in 2026 to USD 289.77 billion by 2034, exhibiting a CAGR of 19.16% during the forecast period. North America dominated the global market with a 48.06% market share in 2025, supported by favorable reimbursement policies, advanced healthcare infrastructure, and widespread adoption of digital health technologies.

Remote patient monitoring devices enable healthcare providers to remotely collect, monitor, and analyze patient health data using connected medical devices and digital platforms. These solutions improve disease management, reduce hospital visits, and facilitate timely medical intervention, especially for patients suffering from chronic conditions such as cardiovascular diseases, diabetes, hypertension, and respiratory disorders.

Market Definition and Scope

Remote patient monitoring (RPM) refers to the use of connected medical devices, wearable sensors, cloud-based software, and digital communication technologies to monitor patients' health outside traditional healthcare settings. These systems continuously collect vital health parameters, including blood pressure, blood glucose, heart rate, oxygen saturation, respiratory rate, and body temperature, allowing healthcare professionals to provide timely clinical decisions and personalized care.

The market includes remote monitoring devices, digital healthcare platforms, software services, and integrated monitoring solutions used by hospitals, clinics, healthcare providers, payers, and patients. Growing investments in healthcare digitization, artificial intelligence (AI), Internet of Things (IoT), and wearable medical technologies continue to expand the application scope of remote patient monitoring devices globally.

Market Dynamics

Drivers

The increasing burden of chronic diseases and the rapidly growing geriatric population are the primary drivers of market growth. Patients suffering from cardiovascular diseases, diabetes, hypertension, respiratory disorders, and cancer require continuous monitoring, making RPM solutions an essential part of modern healthcare delivery.

Another significant growth driver is the rising adoption of telehealth and digital healthcare services. Favorable reimbursement policies, increasing healthcare investments, and technological advancements have encouraged hospitals and healthcare providers to implement remote monitoring programs. Consumers are also increasingly adopting connected healthcare devices to reduce hospital visits and improve disease management.

Trends

One of the major trends transforming the market is the integration of Artificial Intelligence (AI) and the Internet of Things (IoT) into remote patient monitoring systems. AI-powered analytics help clinicians identify health risks earlier, while IoT-enabled wearable devices provide continuous real-time monitoring through cloud-based platforms.

Another important trend is the growing launch of next-generation wearable monitoring devices capable of tracking multiple vital signs simultaneously. Medical device manufacturers are focusing on wireless, contactless, and smartphone-connected monitoring technologies to improve patient convenience and healthcare efficiency.

Restraints

Despite strong market growth, high implementation and maintenance costs remain a major challenge, particularly in low- and middle-income countries. Healthcare providers often require significant investments in medical devices, cloud infrastructure, IT systems, and trained personnel.

Additionally, limited reimbursement policies, inadequate healthcare infrastructure, lower internet accessibility, and lack of awareness regarding remote monitoring solutions in developing regions continue to restrict broader market adoption.

Impact of COVID-19

The COVID-19 pandemic significantly accelerated the adoption of remote patient monitoring devices worldwide. Movement restrictions and the need to minimize physical interaction encouraged healthcare providers to utilize remote monitoring technologies for patient care. Hospitals increasingly adopted connected medical devices to monitor COVID-19 patients remotely, reducing infection risks while ensuring continuous healthcare services. The pandemic also boosted product sales, encouraged investments in digital healthcare, and strengthened long-term adoption of RPM technologies across global healthcare systems.

Segmentation Analysis

By type, the Services segment is expected to dominate the market, accounting for 64.18% of the global market in 2026, owing to increasing demand for remote healthcare services, cloud-based monitoring platforms, and virtual patient care. Meanwhile, the Devices segment is projected to witness significant growth due to continuous product innovations, wearable technologies, and increasing adoption of patient-centric monitoring solutions.

By application, Cardiovascular Diseases will remain the leading segment, accounting for 47.27% of the market in 2026. The growing prevalence of heart diseases and increasing demand for blood pressure monitors, ECG devices, and cardiac monitoring systems continue to support segment growth. The Diabetes segment is also expected to register rapid growth due to rising adoption of continuous glucose monitoring devices.

By end-user, the Providers segment is projected to hold 47.38% of the market in 2026, driven by increasing implementation of RPM solutions across hospitals, clinics, and healthcare organizations. The Patients segment is anticipated to grow rapidly as awareness of home healthcare and remote disease management continues to increase.

Regional Insights

North America dominated the global remote patient monitoring devices market with a valuation of USD 28.80 billion in 2025, which is projected to increase to USD 34.31 billion in 2026. The region benefits from advanced healthcare infrastructure, strong regulatory support, favorable reimbursement policies, and high prevalence of chronic diseases.

Europe is the second-largest regional market, supported by well-established healthcare systems, favorable regulations, and increasing partnerships among healthcare technology companies. Asia Pacific is expected to witness the fastest growth due to rising healthcare digitization, expanding smartphone penetration, growing elderly population, and increasing investments in healthcare infrastructure across China, India, Japan, and Southeast Asia. Latin America and the Middle East & Africa are gradually expanding due to improving healthcare infrastructure and growing awareness regarding digital healthcare technologies.

Competitive Landscape

The global remote patient monitoring devices market is highly competitive, with leading companies focusing on product innovation, artificial intelligence integration, wearable technologies, strategic partnerships, and acquisitions to strengthen their market positions. Continuous investment in digital healthcare platforms and cloud-based monitoring solutions remains a key competitive strategy.

Major companies operating in the market include Koninklijke Philips N.V., Medtronic, A&D Company, Boston Scientific Corporation, GE Healthcare, Omron Corporation, VitalConnect, OSPLabs, 100Plus, Nihon Kohden Corporation, and F. Hoffmann-La Roche AG.

Report Coverage

This report provides a comprehensive analysis of the global remote patient monitoring devices market, covering market size for 2025, 2026, and 2034, key growth drivers, emerging trends, restraints, COVID-19 impact, segmentation by type, application, and end-user, regional insights, competitive landscape, and recent industry developments. The report also presents country-level analysis and evaluates the latest technological advancements shaping the future of digital healthcare and remote patient monitoring.

Conclusion

The global remote patient monitoring devices market is projected to expand from USD 59.92 billion in 2025 to USD 289.77 billion by 2034, demonstrating exceptional growth driven by increasing chronic disease prevalence, rapid healthcare digitization, AI and IoT integration, and rising adoption of telehealth services. Despite challenges related to implementation costs and limited infrastructure in developing regions, continuous technological advancements, supportive reimbursement policies, and growing demand for home-based healthcare will continue to drive the long-term growth of the global remote patient monitoring devices market.

Segmentation By Type

• Products
  • Multi-parameter Monitoring
  • Respiratory Monitoring
  • Blood Glucose Monitoring
  • Cardiac Monitoring
  • Others
• Services

By Application

• Oncology
• Diabetes
• Cardiovascular Diseases
• Others

By End-user

• Payers
• Providers
• Patients

By Geography

• North America (By Type, By Application, By End-user, and By Country)
  • U.S. (By Application)
  • Canada (By Application)
• Europe (By Type By Application, By End-user, and By Country/Sub-Region)
  • U.K. (By Application)
  • Germany (By Application)
  • France (By Application)
  • Italy (By Application)
  • Spain (By Application)
  • Scandinavia (By Application)
  • Rest of Europe (By Application)
• Asia Pacific (By Type, By Application, By End-user, and By Country/Sub-Region)
  • China (By Application)
  • Japan (By Application)
  • India (By Application)
  • Australia (By Application)
  • Southeast Asia (By Application)
  • Rest of Asia Pacific (By Application)
• Latin America (By Type, By Application, By End-user, and By Country/Sub-Region)
  • Brazil (By Application)
  • Mexico (By Application)
  • Rest of Latin America (By Application)
• Middle East & Africa (By Type, By Application, By End-user, and By Country/Sub-Region)
  • GCC (By Application)
  • South Africa (By Application)
• Rest of Middle East & Africa (By Application)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Chronic and Infectious Diseases- Key Countries/Region, 2025
• 4.2. Technological Advancements in Remote Patient Monitoring Devices
• 4.3. Key Industry Developments - Mergers, Acquisitions and Partnerships,
• 4.4. New Product Launches, By Key Players
• 4.5. Impact of COVID-19 on Remote Patient Monitoring Devices Market

5. Global Remote Patient Monitoring Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Products
    • 5.1.1.1. Multi-parameter Monitoring
    • 5.1.1.2. Respiratory Monitoring
    • 5.1.1.3. Blood Glucose Monitoring
    • 5.1.1.4. Cardiac Monitoring
    • 5.1.1.5. Others
  • 5.1.2. Services
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Oncology
  • 5.2.2. Diabetes
  • 5.2.3. Cardiovascular Diseases
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Payers
  • 5.3.2. Providers
  • 5.3.3. Patients
• 5.4. Market Analysis, Insights and Forecast - By Geography
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Remote Patient Monitoring Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Products
    • 6.1.1.1. Multi-parameter Monitoring Devices
    • 6.1.1.2. Respiratory Monitoring
    • 6.1.1.3. Blood Glucose Monitoring
    • 6.1.1.4. Cardiac Monitoring
    • 6.1.1.5. Others
  • 6.1.2. Services
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Oncology
  • 6.2.2. Diabetes
  • 6.2.3. Cardiovascular Diseases
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Payers
  • 6.3.2. Providers
  • 6.3.3. Patients
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
    • 6.4.1.1. By Application
  • 6.4.2. Canada
    • 6.4.2.1. By Application

7. Europe Remote Patient Monitoring Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Products
    • 7.1.1.1. Multi-parameter Monitoring
    • 7.1.1.2. Respiratory Monitoring
    • 7.1.1.3. Blood Glucose Monitoring
    • 7.1.1.4. Cardiac Monitoring
    • 7.1.1.5. Others
  • 7.1.2. Services
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Oncology
  • 7.2.2. Diabetes
  • 7.2.3. Cardiovascular Diseases
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Payers
  • 7.3.2. Providers
  • 7.3.3. Patients
• 7.4. Market Analysis, Insights and Forecast - By Country/Sub-Region
  • 7.4.1. U.K.
    • 7.4.1.1. By Application
  • 7.4.2. Germany
    • 7.4.2.1. By Application
  • 7.4.3. France
    • 7.4.3.1. By Application
  • 7.4.4. Spain
    • 7.4.4.1. By Application
  • 7.4.5. Italy
    • 7.4.5.1. By Application
  • 7.4.6. Scandinavia
    • 7.4.6.1. By Application
  • 7.4.7. Rest of Europe
    • 7.4.7.1. By Application

8. Asia Pacific Remote Patient Monitoring Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Products
    • 8.1.1.1. Multi-parameter Monitoring
    • 8.1.1.2. Respiratory Monitoring
    • 8.1.1.3. Blood Glucose Monitoring
    • 8.1.1.4. Cardiac Monitoring
    • 8.1.1.5. Others
  • 8.1.2. Services
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Oncology
  • 8.2.2. Diabetes
  • 8.2.3. Cardiovascular Diseases
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Payers
  • 8.3.2. Providers
  • 8.3.3. Patients
• 8.4. Market Analysis, Insights and Forecast - By Country/Sub-Region
  • 8.4.1. Japan
    • 8.4.1.1. By Application
  • 8.4.2. Australia
    • 8.4.2.1. By Application
  • 8.4.3. China
    • 8.4.3.1. By Application
  • 8.4.4. India
    • 8.4.4.1. By Application
  • 8.4.5. Southeast Asia
    • 8.4.5.1. By Application
  • 8.4.6. Rest of Asia Pacific
    • 8.4.6.1. By Application

9. Latin America Remote Patient Monitoring Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Products
    • 9.1.1.1. Multi-parameter Monitoring
    • 9.1.1.2. Respiratory Monitoring
    • 9.1.1.3. Blood Glucose Monitoring
    • 9.1.1.4. Cardiac Monitoring
    • 9.1.1.5. Others
  • 9.1.2. Services
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Oncology
  • 9.2.2. Diabetes
  • 9.2.3. Cardiovascular Diseases
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Payers
  • 9.3.2. Providers
  • 9.3.3. Patients
• 9.4. Market Analysis, Insights and Forecast - By Country/Sub-Region
  • 9.4.1. Brazil
    • 9.4.1.1. By Application
  • 9.4.2. Mexico
    • 9.4.2.1. By Application
  • 9.4.3. Rest of Latin America
    • 9.4.3.1. By Application

10. Middle East & Africa Remote Patient Monitoring Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Products
    • 10.1.1.1. Multi-parameter Monitoring
    • 10.1.1.2. Respiratory Monitoring
    • 10.1.1.3. Blood Glucose Monitoring
    • 10.1.1.4. Cardiac Monitoring
    • 10.1.1.5. Others
  • 10.1.2. Services
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Oncology
  • 10.2.2. Diabetes
  • 10.2.3. Cardiovascular Diseases
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Payers
  • 10.3.2. Providers
  • 10.3.3. Patients
• 10.4. Market Analysis, Insights and Forecast - By Country/Sub-Region
  • 10.4.1. GCC Countries
    • 10.4.1.1. By Application
  • 10.4.2. South Africa
    • 10.4.2.1. By Application
  • 10.4.3. Rest of Middle East & Africa
    • 10.4.3.1. By Application

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Koninklijke Philips N.V.
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Medtronic
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. A&D Company, Limited
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Boston Scientific Corporation
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. GE Healthcare
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Omron Corporation
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. VitalConnect
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. OSPLabs
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. 100-Plus
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. Nihon Kohden Corporation
    • 11.2.10.1. Overview
    • 11.2.10.2. Products & Services
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)
  • 11.2.11. F. Hoffmann-La Roche Ltd
    • 11.2.11.1. Overview
    • 11.2.11.2. Products & Services
    • 11.2.11.3. SWOT Analysis
    • 11.2.11.4. Recent Developments
    • 11.2.11.5. Strategies
    • 11.2.11.6. Financials (Based on Availability)